1,722
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluation

LCZ696: a new paradigm for the treatment of heart failure?

, MSc, , MSc, , PhD, , PhD & , MD PhD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Ali Bağcı, Fatih Aksoy, Hasan Aydin Baş, İsmail Barkin Işık & Hikmet Orhan. (2021) The effect of Systolic and diastolic blood pressure on Tp-e interval in patients divided according to World Health Organization classification for body mass index. Clinical and Experimental Hypertension 43:7, pages 642-646.
Read now
Ali Bağcı & Fatih Aksoy. (2021) The frontal plane QRS-T angle may affect our perspective on prehypertension: A prospective study. Clinical and Experimental Hypertension 43:5, pages 402-407.
Read now
Sercan Okutucu, Cengiz Sabanoglu, Begum Yetis Sayin, Hakan Aksoy, Nurbanu Bursa & Ali Oto. (2020) Switching from ramipril to sacubitril/valsartan favorably alters electrocardiographic indices of ventricular repolarization in heart failure with reduced ejection fraction. Acta Cardiologica 75:1, pages 20-25.
Read now
Marwa A. A. Ragab, Mohamed A. Korany, Shereen M. Galal & Aya R. Ahmed. (2018) Diode array detection for stability assessment and evaluation of degradation kinetics of newly introduced sacubitril in its supramolecular complex (LCZ696) with valsartan. Journal of Liquid Chromatography & Related Technologies 41:1, pages 33-42.
Read now
Roberto Latini, Serge Masson & Lidia Staszewsky. (2016) Heart failure trials on pharmacological therapy in 2015: lessons learned and future outlook. Expert Review of Cardiovascular Therapy 14:6, pages 703-711.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.